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One of the difficulties in the development of the photodynamic therapy (PDT) is inherent to 
the multidisciplinary feature of this treatment gathering mainly clinicians, physicists, 
biologists, and chemists. Another issue is the great number of biophysical and biochemical 
parameters involved in the design of new photosensitizers as well as in the in vivo 
application of this treatment. We present a global development approach based on the 
methodology and tools of experimental design. Three study cases are developed to assess 
to potential relevance of such an empirical model-based approach for the development of 
PDT. 
 
Methods & Results 
In a first study, an in vitro screening experimental design was carried out. The 
addressed question dealt with the determination of influent factors on the phototoxicity of a 
new photosensitizer based on quantum dots. Five factors were examined: the nature of 
quantum dots, the excitation light wavelength, the incubation time with cells, the 
photoactivable compound concentration and the fluence level. Relevance of each factor was 
finally estimated and compared to identify the significant parameters. In comparison with a 
typical factorial design, the total number of experiments (42 trials) was divided by 5. 
 
In a second study, an in vivo factorial experimental design was applied to detect 
potential synergic effects between four therapeutic factors: the phenotype of the cancer cell 
line, the food type, the nature of photosensitizer and the post-injection time, on the in vivo 
selectivity (cancer/normal tissue) of the tested photosensitizers. Results particularly pointed 
out the presence of a statistically significant synergic effect between these four factors and 
provided the optimal modalities to maximize the response in term of tumor-to-normal tissue 
ratio. 
 
In a third study, a Doehlert experimental design associated with a response surface 
model was used to determine the in vivo PDT modalities (photosensitizer concentration, 
irradiance and fluence) to both minimize the post-treatment growth rate of the tumor and 
maximize its growth delay. Only 13 experimental conditions were tested and the relevance of 
the optimized condition was corroborated by in vivo validation experiments. 
 
Conclusion 
These studies have confirmed the applicability and attractive contributions of 
experimental design techniques in the development and determination of optimal modalities 
of new photosensitizers in PDT. Their main advantages are to a priori organize experiments 
according to specific questions while minimizing the experimental cost and controlling as 
much as possible the experimental uncertainty. 
 
